Cancer, Advanced Recruiting Phase 2 Trials for Nivolumab (DB09035)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

IndicationStatusPhase
DBCOND0041606 (Cancer, Advanced)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03980041Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275)Treatment
NCT02996110A Study to Test Combination Treatments in People With Advanced Renal Cell CarcinomaTreatment
NCT03219775Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell CarcinomaTreatment